% | $
Quotes you view appear here for quick access.

MannKind Corp. Message Board

  • slevenlord slevenlord Jul 10, 2013 8:35 PM Flag

    Study the Mann

    I've often hear arguments that Al will sell his shares the minute he can.

    Do you really think he sank hundreds of millions of dollars into this thing, put 10 years of life his into it, and staked his reputation and legacy just to walk away now -- before the stock reaches its full potential?

    Don't be silly. Study the "Mann" (no pun intended). He launched Minined and didn't walk away unti the product launched and was fully successful. That's when he sold his shares. And he will do the same thing here. Only this has been a longer, harder road. Al Mann will not sell his shares until this thing is worth several hundred dollars a share, if not more.

    Don't forget, he's nearly 90. He can't take it with him. He has all the money he needs to live out his days. It's all about his legacy, his charities, and his kids (in that order). Al wants Google and Apple kind of money. And he'll stick around until he gets it.

    So the question is: are you brave enough to stick out with him? When you think of the potential this drug and this delivery system have, a $500+/share price four years from now is not out of the realm of possibility.

    Those are my thoughts and observations based on watching this stock and this CEO for the last 15 years. Again, "study the mann." You can make your own conclusions. And by the way, I don't have a crystal ball. So I have to idea what will happen or where this is headed. Hopefully the results are good. Hopefully Afrezza gets approved. And if all that happens, I would imagine Al will act in accordingly.

    Yours truly,

    A humble investor from the Midwest.

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
0.62+0.02(+3.63%)Sep 30 4:00 PMEDT